Shingrix, the vaccine approved last year to prevent shingles, has proved so popular that its maker, GlaxoSmithKline, has not been able to produce it quickly enough.

from Health https://ift.tt/2xBc2Ys

Related Posts:

0 comments:

Post a Comment

Popular Posts